Abstract:RLIM acts as a negative regulator of LIM-Homeodomain proteins either by recruiting Sin3A/Histone Deacetylase (HDAC) co-repressor complex or through degradation of CLIM coactivator, thus playing an important role in embryonic development. Recent studies by different research groups have shown that RLIM acts as an X-encoded, dose-dependent inducer of X chromosome inactivation in mouse embryonic stem cells. However, until now, very little is known about the expression regulation of RLIM gene, and we tried to study the transcriptional regulation of RLIM gene. In the present study, we identified RLIM as a novel target of p53 and demonstrated that p53 repressed both mRNA and protein levels of RLIM. Expression of wild type p53, but not p53 mutants, led to repression of the RLIM promoter activity. We further identified four putative Sp1 elements (S1 to S4) on the RLIM promoter that are essential for p53-mediated repression of RLIM. Although p53 does not directly bind to the RLIM promoter, it physically interacts with and prevents the binding of Sp1 to the RLIM promoter. Thus, RLIM is a novel target of p53, and p53 exerts its inhibitory effect on RLIM expression by interfering with Sp1-mediated transcriptional activation on RLIM. Our results provided data to enlarge the knowledge of transcriptional regulation of RLIM and suggested a new pathway by which physiological and pathological activators of p53 may affect development.

E3 Ubiquitin Ligase RLIM Negatively Regulates c-Myc Transcriptional Activity and Restrains Cell Proliferation

The E3 Ligase Ring1 Targets P53 For Degradation And Promotes Cancer Cell Proliferation And Survival

Regulation of c-Myc protein stability by proteasome activator REG γ

A Positive Feedback Loop Between EBP2 and C-Myc Regulates Rdna Transcription, Cell Proliferation, and Tumorigenesis.

P53 Represses Transcription of Ring Finger Lim Domain-Binding Protein Rlim Through Sp1

RNA-binding motif protein 10 inactivates c-Myc by partnering with ribosomal proteins uL18 and uL5

PDLIM2 is a novel E5 ubiquitin ligase enhancer that stabilizes ROC1 and recruits the ROC1-SCF ubiquitin ligase to ubiquitinate and degrade NF-κB RelA

Ribosomal Protein S14 Negatively Regulates c-Myc Activity

ABLIM1, a novel ubiquitin E3 ligase, promotes growth and metastasis of colorectal cancer through targeting IĸBα ubiquitination and activating NF-ĸB signaling

CRL2 KLHDC3 and CRL1 Fbxw7 cooperatively mediate c-Myc degradation

ELP3 stabilizes c-Myc to promote tumorigenesis

Linc-Ror Promotes C-Myc Expression Through Hnrnp I And Auf1

The Map3k13-Trim25-Fbxw7 Alpha Axis Affects C-Myc Protein Stability And Tumor Development

Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis.

RYBP Modulates Stability and Function of Ring1B Through Targeting UBE3A.

The myostatin-induced E3 ubiquitin ligase RNF13 negatively regulates the proliferation of chicken myoblasts.

Rlim, an E3 Ubiquitin Ligase, Influences the Stability of Stathmin Protein in Human Osteosarcoma Cells

c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis

RNF6 Promotes Chronic Myelogenous Leukemia Cell Proliferation and Migration by Stabilizing Vimentin Via Multiple Atypical Ubiquitinations.

Multifaceted Roles of the E3 Ubiquitin Ligase RING Finger Protein 115 in Immunity and Diseases

PIWIL2 Induces C-Myc Expression by Interacting with NME2 and Regulates C-Myc-mediated Tumor Cell Proliferation.